Advertisement
Advertisement

ZBIO

ZBIO logo

Zenas BioPharma, Inc. Common Stock

19.93
USD
Sponsored
+0.77
+4.02%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

20.29

+0.36
+1.78%

Zenas BioPharma, Inc. Common Stock Profile

About

Zenas BioPharma Inc. is a clinical-stage global biopharmaceutical company. It involved in the development and commercialization of transformative immunology-based therapies for patients in need. The company's lead product candidate includes obexelimab and Fc?RIIb. Zenas BioPharma Inc. is based in WALTHAM, Mass.

Info & Links

CEO

Leon O. Moulder

Headquarters

852 Winter Street, Suite 250
Waltham, MA 02451, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.zenasbio.com

Auditor

Ernst & Young LLP

Share holders

58

Employees

167

Zenas BioPharma, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.27B

Enterprise Value

1.23B

Enterprise Value/EBITDA(ttm)

-3.22

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.72

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-83.93%

Return on Equity(ttm)

-156.98%

Return on Invested Capital(ttm)

-127.67%

Return on Assets(ttm)

-113.39%

Income Statement

Revenue(ttm)

10.00M

Revenue Per Share(ttm)

0.17

Gross Profit(ttm)

10.00M

EBITDA(ttm)3

-383.00M

Net Income Available to Common(ttm)

-377.74M

Diluted EPS(ttm)

-7.81

Share Statistics

Beta (5Y Monthly)

-0.54

52-Week Change

119.25%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

57.36M

Dividend Yield

0.00%

Float4

44.75M

% Held by Insiders

22.00%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

343.19M

Total Cash Per Share(mrq)

5.98

Total Debt(mrq)

78.64M

Total Debt/Equity(mrq)

32.47%

Current Ratio(mrq)

5.61%

Quick Ratio(mrq)

5.61%

Book Value Per Share(mrq)

4.44

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.85

Free Cash Flow(ytd)

-172.35M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement